Amendments have been made to the order of the Acting Chairman of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan dated November 19, 2024 No. 514-НК "On the suspension of certain registration certificates of medicines". The expert organization has been instructed to renew the registration certificates and certificates of conformity of products issued for medicines:
– No. RK-LS-5№025021 “Medocef, powder for solution for intravenous and intramuscular administration, 1 g”,
– No. RK-LS-5№121700 “Archimax, powder for solution for intravenous administration, 1000 mg”,
– No. RK-LS-5№025190 “Medaxone, powder for the preparation of a solution for intramuscular injection complete with a solvent (lidocaine hydrochloride solution 1%)”,
– No. RK-LS-5№025197 “Medaxone, powder for solution for intravenous and intramuscular administration, 1 g”,
– No. RK-LS-5№025198 “Medaxone, powder for solution for intravenous and intramuscular administration, 2 g”,
– No. RK-LS-5№025232 “Zyban, powder for solution for intravenous and intramuscular administration, 2 g”,
– No. RK-LS-5№025233 “Zyban, powder for solution for intravenous and intramuscular administration, 1 g”,
– No. RK-LS-5№014457 “Medoflucon, capsules, 150 mg”.
Basis: appeals outgoing No. Reg/Out/8591 dated November 22, 2024, Reg/Out/8594 dated November 25, 2024 from IP Registrarius, service note
No. -0/39383-vn dated November 29, 2024.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
– No. RK-LS-5№025021 “Medocef, powder for solution for intravenous and intramuscular administration, 1 g”,
– No. RK-LS-5№121700 “Archimax, powder for solution for intravenous administration, 1000 mg”,
– No. RK-LS-5№025190 “Medaxone, powder for the preparation of a solution for intramuscular injection complete with a solvent (lidocaine hydrochloride solution 1%)”,
– No. RK-LS-5№025197 “Medaxone, powder for solution for intravenous and intramuscular administration, 1 g”,
– No. RK-LS-5№025198 “Medaxone, powder for solution for intravenous and intramuscular administration, 2 g”,
– No. RK-LS-5№025232 “Zyban, powder for solution for intravenous and intramuscular administration, 2 g”,
– No. RK-LS-5№025233 “Zyban, powder for solution for intravenous and intramuscular administration, 1 g”,
– No. RK-LS-5№014457 “Medoflucon, capsules, 150 mg”.
Basis: appeals outgoing No. Reg/Out/8591 dated November 22, 2024, Reg/Out/8594 dated November 25, 2024 from IP Registrarius, service note
No. -0/39383-vn dated November 29, 2024.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
